ARTEMIS

Biologics, namely, chimeric immune cell antigen receptors, namely, engineered immune cells made from an individual patient's immune cells and proprietary DNA, for therapeutic use for the treatment of cancers, for the treatment of proliferative cell diseases, and in transplantation